Should You Continue to Retain Abbott Stock in Your Portfolio Now? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. Within Established Pharmaceuticals (“EPD”), the company is driving robust growth in key therapeutic areas and advancing in the biosimilar strategy. However, macroeconomic impacts and adverse currency fluctuations may hurt Abbott's financial performance. In the past year, this Zacks Rank #3 (Hold) stock has rallied 26.4% compared with the 9% rise of the industry and 8.8% growth of the S&P 500 composite. The healthcare giant has a market capitalization of $231.38 billion. The company's earnings yield of 3.9% is well above the industry's 0.5%. Abbott surpassed estimates in three of the trailing four quarters and broke even in one, delivering an average earnings surprise of 1.6%. Strong Prospects Within Core Diagnostics: Abbott continues to expand its Diagnostics business foothold (consisting of 20% of the total revenues in the f
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise? [Yahoo! Finance]Yahoo! Finance
- Japan Point-Of-Care Testing Market Set to Reach US$ 4,557.56 Million By 2033 | Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) Expands Diabetes Care with FreeStyle Libre 3 Plus Launch in Canada [Yahoo! Finance]Yahoo! Finance
- Should You Buy Abbott Stock At $135? [Forbes]Forbes
- Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/25 - Beat
ABT
Sec Filings
- 7/1/25 - Form 4
- 7/1/25 - Form 4
- 7/1/25 - Form 4
- ABT's page on the SEC website